GeneDx delivers personalized and actionable health insights that inform diagnosis, direct treatment and improve drug discovery. The company is transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets and its powerful clinical interpretation engine, Centrellis. GeneDx is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care.
AAP Nat Con